A prospective, multi-centre US clinical trial to determine accuracy of FebriDx point-of-care testing for acute upper respiratory infections with and without a confirmed fever

References

• Harris AM, Hicks LA, Qaseem A. for the High Value Care Task Force of the American College of Physicians and for the Centers for Disease Control and Prevention. Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high-value care from the American college of physicians and the centers for disease control and prevention. Ann Intern Med. 2016;164:425–434.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2013. Atlanta (GA): Centers for Disease Control and Prevention; 2014 [cited 2015 Sep 25]. Available at www.cdc.gov/drugresistance/threat-report-2013
   Google Scholar
• Shehab N, Patel PR, Srinivasan A, et al. Emergency department visits for antibiotic-associated adverse events. Clin Infect Dis. 2008;47:735–743.
   PubMed Web of Science ®Google Scholar
• Dellit TH, Owens RC, McGowan JE, Jr, et al. Infectious diseases society of America and the society for healthcare epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159–177.
   PubMed Web of Science ®Google Scholar
• Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372:825–834.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Get Smart: Know when antibiotics work. 2016 [cited 2016 May 5]. Available at: http://www.cdc.gov/getsmart/community/index.html
   Google Scholar
• Caliendo AM, Gilbert DN, Ginocchio CC, Infectious Diseases Society of America (IDSA, et al. Better tests, better care: improved diagnostics for infectious diseases. Clin Infect Dis. 2013;57(Suppl 3):S139–S170.
   PubMed Web of Science ®Google Scholar
• Self WH, Rosen J, Sharp SC, et al. Diagnostic accuracy of FebriDx: a rapid test to detect immune responses to viral and bacterial upper respiratory infections. JCM. 2017;6:E94.
   Google Scholar
• Davidson M. FebriDx point-of-care testing to guide antibiotic therapy for acute respiratory tract infection in UK primary care: a retrospective outcome analysis. J Infect Dis Preve Med. 2017;5:165.
   Google Scholar
• Sambursky R, Shapiro N. Evaluation of a combined MxA and CRP point-of-care immunoassay to identify viral and/or bacterial immune response in patients with acute febrile respiratory infection. Eur Clin Respir J. 2015; 2:28245.
   PubMed Web of Science ®Google Scholar
• Joseph P, Godofsky E. Outpatient antibiotic stewardship: a growing frontier—combining myxovirus resistance protein a with other biomarkers to improve antibiotic use. Open Forum Infect Dis. 2018;5:ofy024.
   PubMed Web of Science ®Google Scholar
• Engelmann I, Dubos F, Lobert PE, et al. Diagnosis of viral infections using Myxovirus resistance protein A (MxA). Pediatrics. 2015;135:e985–e993.
   PubMed Web of Science ®Google Scholar
• FebriDx Package insert. 2018 [cited 2018 Jan]. Available at https://www.rpsdetectors.com/wp-content/uploads/2015/05/SPEC-MKT-044.2_FebriDx-Package-Insert-CE-Mark.pdf
   Google Scholar
• Schuetz P, Briel M, Mueller B. Clinical outcomes associated with procalcitonin algorithms to guide antibiotic therapy in respiratory tract infections. JAMA. 2013;309:717–1718.
   PubMed Web of Science ®Google Scholar
• Musher DM, Bebko SP, Roig IL. Serum procalcitonin level, viral polymerase chain reaction analysis, and lower respiratory tract infection. J Infect Dis. 2014;209:631–633.
   PubMed Web of Science ®Google Scholar
• Singleton RJ, Bulkow LR, Miernyk K, et al. Viral respiratory infections in hospitalized and community control children in Alaska. J Med Virol. 2010;82:1282–1290.
   PubMed Web of Science ®Google Scholar
• Self WH, Zhu Y, Williams DJ, et al. Respiratory viral detection in children and adults: comparing asymptomatic controls and patients with community-acquired pneumonia. J Infect Dis. 2016;213:584–591.
   PubMed Web of Science ®Google Scholar
• Jansen RR, Wieringa J, Koekkoek SM, et al. Frequent detection of respiratory viruses without symptoms: toward defining clinically relevant cutoff values. J Clin Microbiol. 2011;49:2631–2636.
   PubMed Web of Science ®Google Scholar
• Jartti T, Jartti L, Peltola V, et al. Identification of respiratory viruses in asymptomatic subjects: asymptomatic respiratory viral infections. Pediatr Infect Dis J. 2008;27:1103–1107.
   PubMed Web of Science ®Google Scholar
• FilmArray Respiratory Panel. BioMerieux. 2016 [cited 2016 Apr 29]. Available at: http://www.biomerieux-diagnostics.com/filmarrayr-respiratory-panel
   Google Scholar
• EBV-VCA IgM Enzyme Immunoassay Test Kit. Diamedix. 2016 [cited 2016 Apr 29]. Available at: http://diamedix.com/wp-content/uploads/2015/10/PI-EBVVCAIgM-720610-Rev7-June-15.pdf
   Google Scholar
• BRAHMS PCT Sensitive KRYPTOR. Thermo Fisher Scientific. 2016 [cited 2016 Apr 29]. Available at: http://www.procalcitonin.com/
   Google Scholar
• Korppi M, Kroger L, Laitinen M. White blood cell and differential counts in acute respiratory viral and bacterial infections in children. Scand J Infect Dis. 1993;25:435–440.
   PubMed Web of Science ®Google Scholar
• Casey JR, Marsocci SM, Murphy ML, et al. White blood cell count can aid judicious antibiotic prescribing in acute upper respiratory infections in children. Clin Pediatr (Phila). 2003;42:113–119.
   PubMed Web of Science ®Google Scholar
• Burkhardt O, Ewig S, Haagen U, et al. Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection. Eur Respir J. 2010;36:601–607.
   PubMed Web of Science ®Google Scholar
• Elsammak M, Hanna H, Ghazal A, et al. Diagnostic value of serum procalcitonin and C-reactive protein in Egyptian children with streptococcal tonsillopharyngitis. Pediatr Infect Dis J. 2006;25:174–176.
   PubMed Web of Science ®Google Scholar
• Briel M, Schuetz P, Mueller B, et al. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med. 2008;168:2000–2007.
   PubMed Web of Science ®Google Scholar
• Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and c-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39:206–217.
   PubMed Web of Science ®Google Scholar
• Eccles S, Pincus C, Higgins B, Guideline Development Group, et al. Diagnosis and management of community and hospital acquired pneumonia in adults: summary of NICE guidance. BMJ. 2014;349:g6722.
   PubMed Web of Science ®Google Scholar
• Huang Y, Chen R, Wu T, et al. Association between point-of-care CRP testing and antibiotic prescribing in respiratory tract infections: a systematic review and meta-analysis of primary care studies. Br J Gen Pract. 2013;63:e787–e794.
   PubMed Web of Science ®Google Scholar
• Staeheli P, Pitossi F, Pavlovic J. Mx proteins: GTPases with antiviral activity. Trends Cell Biol. 1993;3:268–272.
   PubMedGoogle Scholar
• Roers A, Hochkeppel HK, Horisberger MA, et al. MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon. J Infect Dis. 1994;169:807–813.
   PubMed Web of Science ®Google Scholar
• Chieux V, Hober D, Harvey J, et al. The MxA protein levels in whole blood lysates of patients with various viral infections. J Virol Methods. 1998;70:183–191.
   PubMed Web of Science ®Google Scholar
• Petersen I, Johnson AM, Islam A, et al. Protective effect of antibiotics against serious complications of common respiratory tract infections: Retrospective cohort study with the UK general practice research database. BMJ. 2007;335:982
   PubMed Web of Science ®Google Scholar
• Melbye H, Hvidsten D, Holm A, et al. The course of C-reactive protein response in untreated upper respiratory tract infection. Br J Gen Pract. 2004;54:653–658.
   PubMed Web of Science ®Google Scholar
• Snellman LW, Stang HJ, Stang JM, et al. Duration of positive throat cultures for group A streptococci after initiation of antibiotic therapy. Pediatrics. 1993;91:1166–1170.
   PubMed Web of Science ®Google Scholar
• Kiem S, Schentag JJ. Correlations between microbiological outcomes and clinical responses in patients with severe pneumonia. Infect Chemother. 2013;45:283–291.
   PubMedGoogle Scholar
• Musher D. Clinical and microbiological end points in the treatment of pneumonia. Clin Infect Dis. 2008;47:S207–S209.
   PubMed Web of Science ®Google Scholar
• Lingard H, Zehetmayer S, Maier M. Bacterial superinfection in upper respiratory tract infections estimated by increases in CRP values: a diagnostic follow‐up in primary care. Scand J Prim Health Care. 2008;26:211–215.
   PubMed Web of Science ®Google Scholar
• Prat C, Lacoma A. Bacteria in the respiratory tract-how to treat? Or do not treat? Int J Infect Dis. 2016;51:113–122.
   PubMed Web of Science ®Google Scholar
• Bosch AA, Biesbroek G, Trzcinski K, et al. Viral and bacterial interactions in the upper respiratory tract. PLoS Pathog. 2013;9:e1003057.
   PubMed Web of Science ®Google Scholar
• Kaplan EL, Top FH, Jr., Dudding BA, et al. Diagnosis of streptococcal pharyngitis: differentiation of active infection from the carrier state in the symptomatic child. J Infect Dis. 1971;123:490–501.
   PubMed Web of Science ®Google Scholar
• Kaplan EL. The group A streptococcal upper respiratory tract carrier state: an enigma. J Pediatr. 1980;97:337–345.
   PubMed Web of Science ®Google Scholar
• Gerber MA, Randolph MF, Mayo DR. The group A streptococcal carrier state. A reexamination. Am J Dis Child. 1988;142:562–565.
   PubMedGoogle Scholar
• Shapiro DJ, Hick LA, Pavia AT, et al. Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09. J Antimicrob Chemother. 2014;69:234–240.
   PubMed Web of Science ®Google Scholar
• Fleming-Dutra KE, Hersh AL, Shapiro DJ. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010-2011. JAMA. 2016;315:1864–1873.
   PubMed Web of Science ®Google Scholar
• Stein M, Lipman-Arens S, Oved K, et al. A novel host-protein assay outperforms routine parameters for distinguishing between bacterial and viral lower respiratory tract infections. Diagn Microbiol Infect Dis. 2018;90:206–213.
   PubMed Web of Science ®Google Scholar
• van Houten CB, de Groot JAH, Klein A, et al. A host-protein based assay to differentiate between bacterial and viral infection in preschool children (OPPORTUNITY): a double-blind, multicentre, validation study. Lancet Infect Dis. 2017;17:431–440.
   PubMed Web of Science ®Google Scholar
• Srugo I, Klein A, Stein M, et al. Validation of a novel assay to distinguish bacterial and viral infections. Pediatrics. 2017;140:e20163453.
   PubMed Web of Science ®Google Scholar
• Sweeney TE, Wong HR, Khatri P. Robust classification of bacterial and viral infections via integrated host gene expression diagnostics. Sci Transl Med. 2016;8:346ra91.
   PubMed Web of Science ®Google Scholar
• Christensen AM, Thomsen MK, Ovesen T, et al. Are procalcitonin or other infection markers useful in the detection of group A streptococcal acute tonsillitis? Scand J Infect Dis. 2014;46:376–383.
   PubMed Web of Science ®Google Scholar